2m 2m 2m 2m 2m 2m 2m
PERSPECTIVE TH-B (CATX)
NYSE
$3.58-$0.02 (-0.56%)
Price as of Jun 03, 2026 7:55 PM EDT- $449.3MMarket Cap
- 16.50%1-Year Change
- Medical DevicesIndustry
PERSPECTIVE TH-B (CATX)
$3.58-$0.02 (-0.56%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | N/A N/A | N/A N/A | 1.4M -60.59% | 3.6M -64.67% | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | 2.7M -44.55% | |
Gross Profit | 0 N/A | 0 -100.00% | 1.4M +75.52% | 817,000 -84.05% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | 1.6M -33.85% | |
Research and Development Expense | -84.2M +102.26% | -41.6M +95.38% | -21.3M +1,538.05% | -1.3M -8.83% | |
Depreciation and Amortization Expense | 3.3M +40.98% | 2.3M +143.76% | 946,000 +585.51% | 138,000 -7.38% | |
Total Operating Expenses | 114.4M +23.94% | 92.3M +117.91% | 42.4M +386.34% | 8.7M +1.70% | |
Operating Profit | -113.6M +24.95% | -90.9M +121.99% | -40.9M +418.50% | -7.9M +129.14% | |
Interest Income | 8.1M -22.83% | 10.5M +1,025.80% | 934,000 +66.49% | 561,000 +850.85% | |
Interest Expense | N/A N/A | N/A N/A | -84,000 N/A | N/A N/A | |
Interest Income and Expense and Net | 8.1M -22.83% | 10.5M +1,137.06% | 850,000 +51.52% | 561,000 +850.85% | |
Total Nonoperating Income and Expense | 9.1M -12.65% | 10.5M +1,152.57% | 835,000 +48.84% | 561,000 +850.85% | |
Income before Taxes | -104.4M +29.84% | -80.4M +100.54% | -40.1M +446.78% | -7.3M +116.37% | |
Income Taxes | -793,000 -62.18% | -2.1M -20.90% | -2.7M N/A | 0 N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -103.1M +30.07% | -79.3M +70.46% | -46.5M +534.06% | -7.3M +116.56% | |
Net Income from Continuing Operations Applicable to Common | -104.4M +29.84% | -80.4M +100.54% | -40.1M +446.78% | -7.3M +116.37% | |
Basic EPS and Net Income | -1.40 +13.82% | -1.23 +623.53% | -0.17 +240.00% | -0.05 +66.67% | |
Diluted EPS and Net Income | -1.40 +13.82% | -1.23 +623.53% | -0.17 +240.00% | -0.05 +66.67% | |
Basic Weighted Average Shares | 73.8M +14.57% | 64.4M -75.93% | 267.6M +88.34% | 142.1M +36.85% | |
Diluted Weighted Average Shares | 73.8M +14.57% | 64.4M -75.93% | 267.6M +88.34% | 142.1M +36.85% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 30.6M -50.26% | 61.6M +566.59% | 9.2M -55.99% | 21.0M -67.11% | |
Short-Term Investments | 114.1M -30.98% | 165.3M N/A | 0 -100.00% | 22.8M N/A | |
Cash and Cash Equivalents and Short-Term Investments | 144.7M -36.22% | 226.9M +2,356.33% | 9.2M -78.89% | 43.8M -31.45% | |
Total Current Assets | 148.4M -35.81% | 231.2M +1,272.93% | 16.8M -68.36% | 53.2M -20.93% | |
Accumulated Depreciation | 6.2M +109.59% | 3.0M +342.45% | 669,000 -91.23% | 7.6M +5.28% | |
Property and Plant and Equipment and Net | 76.6M +33.63% | 57.3M +927.99% | 5.6M +231.12% | 1.7M -13.99% | |
Total Long-Term Assets | 486,000 +20.00% | 405,000 -16.84% | 487,000 +106.36% | 236,000 +81.54% | |
Total Assets | 267.0M -21.73% | 341.1M +248.45% | 97.9M +68.51% | 58.1M -17.50% | |
Income Taxes Payable | 1.7M -31.78% | 2.5M -45.67% | 4.6M N/A | N/A N/A | |
Total Short-Term Debt | 56,000 +7.69% | 52,000 +6.12% | 49,000 N/A | N/A N/A | |
Total Current Liabilities | 28.7M +57.32% | 18.2M +16.38% | 15.7M +485.35% | 2.7M +48.58% | |
Total Long-Term Debt | 1.6M -3.45% | 1.6M -3.04% | 1.7M N/A | N/A N/A | |
Total Long-Term Liabilities | 386,000 +601.82% | 55,000 -99.53% | 11.6M +9,934.48% | 116,000 -77.86% | |
Total Liabilities | 59.9M +18.85% | 50.4M +122.05% | 22.7M +558.51% | 3.4M +14.58% | |
Retained Earnings | -334.8M +44.50% | -231.7M +52.01% | -152.4M +43.90% | -105.9M +15.99% | |
Total Stockholders Equity | 207.0M -28.77% | 290.7M +286.63% | 75.2M +37.58% | 54.6M -18.94% | |
Total Shares Outstanding | 74.3M +5.19% | 70.7M -74.92% | 281.8M +98.30% | 142.1M +0.14% | |
Cash Flow | |||||
Cash from Operating Activities | -82.5M +350.88% | -18.3M -50.44% | -36.9M +506.52% | -6.1M +114.52% | |
Capital Expenditures | 12.7M -76.57% | 54.4M +4,975.93% | 1.1M +609.93% | 151,000 -60.37% | |
Cash from Investing Activities | 41.2M +118.83% | -218.9M -998.25% | 24.4M +184.51% | -28.8M +6,933.90% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 10.3M -96.44% | 289.4M +36,764.33% | 785,000 +2,703.57% | 28,000 -99.96% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Return on Assets | -33.92% -6.09% | -36.12% N/A | N/A N/A | N/A N/A | |
Return on Equity | -41.44% -4.39% | -43.34% N/A | N/A N/A | N/A N/A | |
Revenue Growth | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Current Ratio | 5.17 -59.20% | 12.68 N/A | N/A N/A | N/A N/A | |
Cash Ratio | 1.07 -68.38% | 3.38 N/A | N/A N/A | N/A N/A | |
Debt-to-Equity Ratio | 0.008 +34.48% | 0.006 N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | 0.006 +24.49% | 0.005 N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow